How should the nurse interpret the client's new galactorrhea and amenorrhea after starting risperidone?
1The findings are harmless and require no further assessment while symptoms are controlled.
2The findings confirm therapeutic dopamine blockade and should be documented only.
3The findings suggest risperidone-related hyperprolactinemia and should be reported.✓ Correct answer
4The findings indicate neuroleptic malignant syndrome and require cooling measures.
Explanation
Risperidone antagonizes dopamine D2 receptors and can cause persistent prolactin elevation. Galactorrhea and amenorrhea are recognized manifestations and should be reported for ordered evaluation and management rather than dismissed as therapeutic or diagnosed as neuroleptic malignant syndrome.
Why this is correct Risperidone blocks dopamine D2 receptors and can elevate prolactin. Galactorrhea and amenorrhea are labeled manifestations that warrant prescriber notification and appropriate evaluation.
Easy analogy or mental picture Dopamine normally applies a brake to prolactin; D2 blockade releases that brake.
Memory hook Risperidone: prolactin rises, periods may stop.
NCLEX decision rule Link a new endocrine or reproductive symptom to a medication's receptor effect, then report it rather than normalizing it.
Why the other choices are wrong The findings are not harmless or evidence of efficacy, and neuroleptic malignant syndrome presents with features such as fever and rigidity rather than isolated galactorrhea and amenorrhea.
References
1DailyMed: RisperidoneD2 antagonism, hyperprolactinemia, galactorrhea, and amenorrhea
Scenario A 24-year-old female on risperidone 4 mg PO daily for 8 weeks for schizoaffective disorder reports breast tenderness, milk-like nipple discharge, and two missed menstrual periods. She is not sexually active.
Hyperprolactinemia — Elevated serum prolactin; antipsychotic-induced when D2 blockade reduces dopamine's inhibitory effect on lactotrophs in the anterior pituitary.
Tuberoinfundibular pathway — Dopamine pathway from the hypothalamus to the pituitary that suppresses prolactin secretion; blocked by typical antipsychotics and risperidone.
Prolactin-sparing antipsychotic — Atypical antipsychotics with weak D2 binding or partial agonism (aripiprazole, quetiapine, clozapine) that do not elevate prolactin significantly.